期刊文献+

瑞芬太尼对左向右分流婴儿先天性心脏病矫正术麻醉诱导期血流动力学及神经肽Y的影响

Effects of Remifentanil on Hemodynamics and Neuropeptiok in Infants Undergoing Congenital Heart Surgery for Left-to-Right Shunt Lesions During Induction
下载PDF
导出
摘要 目的:研究瑞芬太尼对婴儿先天性心脏病矫正术麻醉诱导期血流动力学及神经肽Y(neuropeptide Y,NPY)的影响,确定适合于婴儿的最佳剂量,为瑞芬太尼的临床应用提供依据。方法:选择拟在体外循环下行房间隔缺损(ASD)或室间隔缺损(VSD)修补术的先天性心脏病婴儿40例,随机进入4种不同剂量瑞芬太尼组[各组10例,0.25μg/kg组、0.50μg/kg组、1.0μg/kg组、2.0μg/kg组]进行麻醉诱导,分别于用药前(进行血气分析)、气管插管后2分钟、5分钟抽取动脉血,测定NPY,记录相应时点的心率,平均动脉压。结果:①心率变化:1.0、2.0μg/kg组气管插管后2分钟、5分钟较用药前下降,均有显著性差异(P<0.05~0.01)。气管插管后2分钟1.0μg/kg组较0.25μg/kg组和气管插管后2分钟、5分钟2.0μg/kg组均较0.25μg/kg组下降,均有显著性差异(P<0.05)。②平均动脉压变化:1.0、2.0μg/kg组气管插管后2分钟、5分钟较用药前下降,均有显著性差异(P<0.05~0.01)。气管插管后2分钟、5分钟0.5、1.0、2.0μg/kg 3组均较0.25μg/kg组下降,有显著性差异(P<0.05)。③NPY含量变化:1.0、2.0μg/kg组气管插管后2分钟、5分钟较用药前下降,均有显著性差异(P<0.05~0.01)。气管插管后2分钟,1.0、2.0μg/kg组较0.25μg/kg组也下降,有显著性差异(P<0.05)。结论:瑞芬太尼用于ASD或VSD修补术患儿麻醉诱导可行性良好,剂量以0.25~0.50μg/kg为佳,可以有效的抑制气管插管应激反应,维持血流动力学稳定,抑制NPY释放。 Objective: To investigate the effects of remifentanil on hemodynemics and neuropeptiok (NPY), in infants undergoing congenital heart surgery during induction, and to determine the optimum doses for infants, thus providing evidence for the clinical practice. Methods: Forty congenital heart desease infants undergoing ASD or VSD procedures were selected. They were randomized to four different remifentanil groups ( D1:0. 25 μg/kg, D2:0. 5 μg/kg, D3 : 1.0 μg/kg, IM:2.0 μg/kg) to receive anesthesia induction. Blood samples were obtained at T1 ( before administration), T2,33 ( 2 and 5 rain after tracheal intubation ) for blood gas analysis and plasma levels of NPY. HR, MAP were also recorded. Results: No statistical significant changes of MAP, HR and NPY were identified (P 〉 0. 05 )in infants of DI and D2 groups. In group D3, there was reduced MAP, HR (P 〈 0. 01 ) and NPY( P 〈 0. 05 ) at T2. However, MAP, HR and NPY were obviously decreased(P 〈 0. 01 ) in group IM at T2 and 33. Conclusion : In infants undergoing ASD or VSD procedures, remifentanil dosages of 0. 25 and 0. 50 μg/kg can effectively suppress the tracheal intubation stress response and suppress plasma NPY increase and maintain stable hemodynamies. Remifentanil should be used with caution in infant with congenital heart disease.
出处 《中国循环杂志》 CSCD 北大核心 2006年第6期465-468,共4页 Chinese Circulation Journal
关键词 婴儿瑞芬太尼 先天性心脏病 血流动力学 神经肽Y Infant Remifentanil Congenital heart disease Hemodynamics Neuropeptide Y
  • 相关文献

参考文献12

  • 1黄悦,杭燕南.小儿瑞芬太尼药动学及临床研究进展[J].国外医学(麻醉学与复苏分册),2005,26(2):114-117. 被引量:81
  • 2Morris MJ,Tortelli CF,Hart DP,et al.Vascular and brain neuropeptide Y in banded and spontaneously hypertensive rats.Peptides,2004,25(8):1313-1319.
  • 3Miller MA,Sagnella GA,Markandu ND,et al.Radioimmunoassay for plasma neuropeptide-Y in physiological and physiopathological states and response to sympathetic activation.Clin Chim Acta,1990,192(1):47-53.
  • 4Davis PJ,Ross AK,Dear Gd GL,et al.Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures.Anesth Analg,2001,93 (6):1393-1401.
  • 5Akpek EA,Erkaya C,Donmez A,et al.Remifentanil use in children undergoing congenital heart surgery for left-to-right shunt lesions.J Cardiothorac Vasc Anesth,2005,19(1):60-66.
  • 6Oda Y,Nishikawa K,Hase I,et al.The short-acting betal-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.Anesth Analg,2005,100(3):733-737,table of contents.
  • 7Tan CH,Onisong MK,Chiu WK.The influence of induction technique on intubating conditions 1 min after rocuronium administration:a comparison of a propofol-ephedrine combination and propofol.Anaesthesia,2002,57 (3):223-226.
  • 8Oczenski W,Krenn H,Dahaba AA,et al.Hemodynamic and catecholamine stress responses to insertion of the Combitube,laryngeal mask airway or tracheal intubation.Anesth Analg,1999,88 (6):1389-1394.
  • 9Akpek EA,Erkaya C,Donmez A,et al.Remifentanil use in children undergoing congenital heart surgery for left-to-right shunt lesions.J cardiothorac Vasc Anesth,2005,19(1):60-66.
  • 10Bergendahl HT,Eksborg S,Kogner P,et al.Neuropeptide Y response to tracheal intubation in anaesthetized children:effects of clonidine vs midazolam as premedication.Br J Anaesth,1999,82(3):391-394.

二级参考文献24

  • 1Davis PJ, Ross AK, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age. Anesth Analg, 1995,80:S93.
  • 2Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting,mu-opioid. Anesth Analg, 1996,83: 646-651.
  • 3Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg, 1993,77:1031-1040.
  • 4Ross AK, Davis PJ, Dear GDEL, et al. Pharmcokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg,2001,93:1393-1401.
  • 5John BE, Anne ML. Use of remifentanil in infants. Paediatric Anaesthesia, 1998,8:437-439.
  • 6Bovill JG, Sebel PS. Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery. Br J Anaesth, 1980,52:795-801.
  • 7Hug CC, Burm AGL, de Lange S. Alfentanil pharmacokinetics in cardiac surgical patients. Anesth Analg, 1994,78:231-239.
  • 8Davis PJ, Wilson AS, Siewers RD, et al. The effects of cardiopulmonary bypass on remifentanil kinetics in children undergoing atrial septal defect repair. Anesth Analg, 1999,89:904-908.
  • 9Russell D, Royston D, Rees PH, et al. Effect of temperature and cardiopulmonary bypass on the pharmacokinetics of remifentanil. Br J Anaesth,1997,79: 456-459.
  • 10Klemola UM, Hiller A. Tracheal intubation after induction of anesthesia in children with propofol-remifentanil or propofol-rocuronium. Can J Anaesth, 2000,47: 854-859.

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部